Report overview
Cold medicines?are?medications?used by people with the?common cold,?cough, or related conditions. There is, however, no good evidence that cough medications reduce coughing.
This report contains market size and forecasts of Cold and Flu Drugs in Global, including the following market information:
Global Cold and Flu Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Cold and Flu Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Antihistamines Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cold and Flu Drugs include Reckitt Benckiser Group, Johnson & Johnson, GlaxoSmithKline, Novartis, Bayer, AstraZeneca, Sun Pharmaceutical Industries, Pfizer and Prestige Brands Holdings and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cold and Flu Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cold and Flu Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cold and Flu Drugs Market Segment Percentages, by Type, 2021 (%)
Antihistamines
Expectorants
Bronchodilators
Decongestants
Antibiotics
Others
Global Cold and Flu Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Cold and Flu Drugs Market Segment Percentages, by Application, 2021 (%)
OTC
Rx
Global Cold and Flu Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Cold and Flu Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cold and Flu Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Cold and Flu Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Reckitt Benckiser Group
Johnson & Johnson
GlaxoSmithKline
Novartis
Bayer
AstraZeneca
Sun Pharmaceutical Industries
Pfizer
Prestige Brands Holdings
Procter & Gamble
